The Hanover Insurance Group, Inc. filings document the regulatory record of a property and casualty insurance holding company with common stock listed on the New York Stock Exchange. Its 8-K reports include results of operations and financial condition, earnings releases and unaudited financial supplements covering underwriting metrics, catastrophe losses, premiums, investment income, book value and related insurance performance measures.
The company’s proxy materials cover annual meeting procedures, shareholder voting matters, board governance and executive compensation disclosures. Other filings record capital-structure activity, including senior unsecured notes, note redemptions, registration-statement references and Form 25 records for the removal of a senior debenture class from exchange listing and registration.
Aristeguieta Francisco reported acquisition or exercise transactions in this Form 4 filing.
HANOVER INSURANCE GROUP director Francisco Aristeguieta received a grant of 843 shares of Common Stock as a compensation award. The grant is in the form of restricted stock units under the 2022 Long-Term Incentive Plan and will vest on the earlier of one year from grant or the next annual meeting, bringing his direct holdings to 5,053 shares.
The Hanover Insurance Group reported several governance and capital actions. The board appointed Patricia A. Norton-Gatto, Senior Vice President and Corporate Controller, as Principal Accounting Officer, replacing CFO Jeffrey M. Farber in that role. Shareholders re-elected eight directors, approved the advisory vote on executive compensation, and ratified PricewaterhouseCoopers LLP as independent auditor for 2026, each with strong support.
The board also terminated the prior share repurchase program and authorized a new $700 million share repurchase program with no time limit, replacing a program that had about $63 million remaining. Repurchases may occur in the open market, through privately negotiated or accelerated transactions, or other methods, at the company’s discretion.
Carlin Jane D reported acquisition or exercise transactions in this Form 4 filing.
HANOVER INSURANCE GROUP, INC. director Jane D. Carlin reported an equity grant in the form of 843 shares of common stock on May 12, 2026. The award was granted at no cash cost to her and is described as restricted stock units under the company’s 2022 Long-Term Incentive Plan.
These units vest on the earlier of the one-year anniversary of the grant date or the date of the next annual meeting. After this grant, Carlin directly holds 3,266 common shares. A footnote also notes an additional 2,306 shares held indirectly in a Rabbi Trust pursuant to deferral agreements, separate from the reported direct holdings.
HANOVER INSURANCE GROUP, INC. director Cynthia Egan reported receiving an equity award in the form of 843 shares of common stock at $0.00 per share, classified as a grant or award acquisition. This grant was issued as restricted stock units under the company’s 2022 Long-Term Incentive Plan.
The units vest on the earlier of the one-year anniversary of the grant date or the next annual meeting, and Egan has elected to defer the grant upon vesting under a deferral agreement. After this award, she directly owns 10,202 shares of common stock, and a footnote states this does not include 977 shares held indirectly in a Rabbi Trust under deferral agreements.
HANOVER INSURANCE GROUP, INC. senior vice president and principal accounting officer Patricia A. Norton-Gatto reported her initial ownership of company securities. She holds 2,440.302 shares of common stock directly, including restricted stock units that vest on the third anniversary of their grant dates.
She also holds stock options to acquire 963 shares of common stock at an exercise price of $173.5600 per share expiring on February 24, 2036, and options for 920 shares at $161.8200 per share expiring on February 25, 2035. The filing lists these as existing positions rather than new transactions.
Hanover Insurance Group Executive Vice President Denise Lowsley sold 1,062 shares of common stock in an open-market transaction. The shares were sold at a price of $188.43 per share. After this sale, she directly holds 3,882.513 Hanover Insurance Group common shares.
THG submitted a Form 144-style disclosure listing planned or recent securities transactions through a broker. The filing identifies a 99-share ESPP purchase settled in cash on 06/28/2024 and 963 shares delivered on 02/28/2025 from restricted stock vesting as compensation. The broker listed is Fidelity Brokerage Services LLC with an address in Smithfield, RI. The filing references the NYSE and a filing date of 05/08/2026.
Hanover Insurance Group Executive Vice President T. Willard Lee reported an open-market sale of 1,000 shares of Common Stock at $183.93 per share. After this transaction, Lee directly holds 5,982.373 shares. This filing reflects a single sale transaction with no derivative securities reported.
Hanover Insurance Group director Cynthia Egan sold 3,400 shares of Common Stock in an open-market transaction at $188.50 per share. After this sale, she directly holds 9,359 shares. A footnote states she also has 977 shares held indirectly, in addition to her direct holdings.
THG filed a Form 144 notice regarding the proposed sale of 1,000 shares of Common Stock through Fidelity Brokerage Services LLC. The filing lists an aggregate amount of $183,930.00 and references 34,986,787 shares (displayed) with an effective notice date of 05/04/2026. The notice records two restricted-stock vesting lots: 792 shares (02/28/2023) and 208 shares (02/26/2024), both labeled as compensation.